Literature DB >> 16183037

Evidence for induced microsomal bilirubin degradation by cytochrome P450 2A5.

A'edah Abu-Bakar1, Michael R Moore, Matti A Lang.   

Abstract

Oxidative metabolism of bilirubin (BR) -- a breakdown product of haem with cytoprotective and toxic properties -- is an important route of detoxification in addition to glucuronidation. The major enzyme(s) involved in this oxidative degradation are not known. In this paper, we present evidence for a major role of the hepatic cytochrome P450 2A5 (Cyp2a5) in BR degradation during cadmium intoxication, where the BR levels are elevated following induction of haem oxygenase-1 (HO-1). Treatment of DBA/2J mice with CdCl(2) induced both the Cyp2a5 and HO-1, and increased the microsomal BR degradation activity. By contrast, the total cytochrome P450 (CYP) content and the expression of Cyp1a2 were down-regulated by the treatment. The induction of the HO-1 and Cyp2a5 was substantial at the mRNA, protein and enzyme activity levels. In each case, the up-regulation of HO-1 preceded that of Cyp2a5 with a 5-10h interval. BR totally inhibited the microsomal Cyp2a5-dependent coumarin hydroxylase activity, with an IC(50) approximately equal to the substrate concentration. The 7-methoxyresorufin 7-O-demethylase (MROD) activity, catalyzed mainly by the Cyp1a2, was inhibited up to 36% by BR. The microsomal BR degradation was inhibited by coumarin and a monoclonal antibody against the Cyp2a5 by about 90%. Furthermore, 7-methoxyresorufin, a substrate for the Cyp1a2, inhibited BR degradation activity by approximately 20%. In sum, the results strongly suggest a major role for Cyp2a5 in the oxidative degradation of BR. Secondly, the coordinated up-regulation of the HO-1 and Cyp2a5 during Cd-mediated injury implicates a network of enzyme systems in the maintenance of balancing BR production and elimination.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183037     DOI: 10.1016/j.bcp.2005.08.009

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  11 in total

Review 1.  Alcoholic Liver Disease: from CYP2E1 to CYP2A5.

Authors:  Tung Ming Leung; Yongke Lu
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

2.  Ethanol induction of CYP2A5: role of CYP2E1-ROS-Nrf2 pathway.

Authors:  Yongke Lu; Xu Hannah Zhang; Arthur I Cederbaum
Journal:  Toxicol Sci       Date:  2012-05-02       Impact factor: 4.849

3.  Up- and down-modulation of liver cytochrome P450 activities and associated events in two murine malaria models.

Authors:  Ana Cecilia A X De-Oliveira; Renato S Carvalho; Flavio H M Paixão; Hellen S Tavares; Luciana S Gueiros; Carolina M Siqueira; Francisco J R Paumgartten
Journal:  Malar J       Date:  2010-03-22       Impact factor: 2.979

4.  A functional link between housekeeping selenoproteins and phase II enzymes.

Authors:  Aniruddha Sengupta; Bradley A Carlson; James A Weaver; Sergey V Novoselov; Dmitri E Fomenko; Vadim N Gladyshev; Dolph L Hatfield
Journal:  Biochem J       Date:  2008-07-01       Impact factor: 3.857

Review 5.  Cytochrome P450s and Alcoholic Liver Disease.

Authors:  Yongke Lu; Arthur I Cederbaum
Journal:  Curr Pharm Des       Date:  2018       Impact factor: 3.116

6.  Transport and metabolism at blood-brain interfaces and in neural cells: relevance to bilirubin-induced encephalopathy.

Authors:  Silvia Gazzin; Nathalie Strazielle; Claudio Tiribelli; Jean-François Ghersi-Egea
Journal:  Front Pharmacol       Date:  2012-05-18       Impact factor: 5.810

7.  Metyrapone, an inhibitor of cytochrome oxidases, does not affect viability in a neuroblastoma cell model of bilirubin toxicity.

Authors:  Maria N Naguib Leerberg; Tomas N Alme; Thor W R Hansen
Journal:  Mol Genet Metab Rep       Date:  2014-04-25

8.  Evidence that the capacity of nongenotoxic carcinogens to induce oxidative stress is subject to marked variability.

Authors:  Colin J Henderson; Amy R Cameron; Lynsey Chatham; Lesley A Stanley; Charles Roland Wolf
Journal:  Toxicol Sci       Date:  2015-02-17       Impact factor: 4.849

9.  Interstrain differences in the expression and activity of Cyp2a5 in the mouse liver.

Authors:  Katia S Poça; Thiago E M Parente; Lucas F Chagas; Bruna S Leal; Hellen S Leal; Francisco J R Paumgartten; Ana C A X De-Oliveira
Journal:  BMC Res Notes       Date:  2017-03-15

10.  Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation.

Authors:  Yizhe Cui; Qiuju Wang; Xiaochong Li; Xiuying Zhang
Journal:  Redox Biol       Date:  2013-08-24       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.